Panmure Gordon (UK) Limited, an exempt principal trader, has disclosed its dealings in the securities of Allergy Therapeutics plc. On August 9, 2023, Panmure Gordon purchased 967,657 0.1p ordinary shares at a price range of 0.0242p to 0.029p per unit. They also sold 13,606 0.1p ordinary shares at a price of 0.028p per unit. No cash-settled derivative transactions or stock-settled derivative transactions were reported. No indemnity or option arrangements, agreements, or understandings were disclosed. The disclosure was made in accordance with Rule 8 of the Takeover Code.